Baclofen suppresses alcohol intake and craving for alcohol in a schizophrenic alcohol-dependent patient: A case report [16]

Journal of Clinical Psychopharmacology

Volumn 27, Issue 3, 2007, Pages 319-320

  Agabio, Roberta ^a   Marras, Priamo ^a   Addolorato, Giovanni ^b   Carpiniello, Bernardo ^a   Gessa, Gian Luigi ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALCOHOL; ASPARTATE AMINOTRANSFERASE; BACLOFEN; BENZODIAZEPINE DERIVATIVE; DISULFIRAM; GAMMA GLUTAMYLTRANSFERASE; HALOPERIDOL;

ADULT; ALCOHOL CONSUMPTION; ALCOHOL INTOXICATION; ALCOHOLISM; ANXIETY; CASE REPORT; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SAFETY; HUMAN; LETTER; MALE; MEAN CORPUSCULAR VOLUME; PRIORITY JOURNAL; SCHIZOPHRENIA; SEDATION; SIDE EFFECT; VISUAL ANALOG SCALE;

ALCOHOL DRINKING; ALCOHOLISM; BACLOFEN; BEHAVIOR, ADDICTIVE; GABA AGONISTS; HUMANS; MALE; MIDDLE AGED; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 34248562397     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jcp.0000270079.84758.fe     Document Type: Letter

References (17)

1. Regier DA, Farmer ME, Rae DS, et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. J Am Med Assoc. 1990;264:2511-2518.
2. Le Fauve CE, Litten RZ, Randall CL, et al. Pharmacological treatment of alcohol abuse/dependence with psychiatric comorbidity. Alcohol Clin Exp Res. 2004;28:302-312.
3. Davidoff RA. Antispasticity drugs: mechanisms of action. Ann Neurol. 1985;17:107-116.
4. Addolorato G, Caputo F, Capristo E, et al. Baclofen efficacy in reducing alcohol craving and intake - a preliminary double blind randomised controlled study. Alcohol Alcohol. 2002;37:504-508.
5. Flannery BA, Garbutt JC, Cody MW, et al. Baclofen for alcohol dependence: a preliminary open-label study. Alcohol Clin Exp Res. 2004;28:1517-1523.
6. Addolorato G, Leggio L, Abenavoli L, et al. Baclofen in the treatment of alcohol withdrawal syndrome: a comparative study vs diazepam. Am J Med. 2006;119:e13-e18.
7. Ameisen O. Complete and prolonged suppression of symptoms and consequences of alcohol-dependence using high-dose baclofen: a self-case report of a physician. Alcohol Alcohol. 2005;40:147-150.
8. Gulmann NC, Bahr B, Andersen B, et al. A double-blind trial of baclofen against placebo in the treatment of schizophrenia. Acta Psychiatr Scand. 1976;54:287-293.
9. Bigelow LB, Nasrallah H, Carman J, et al. Baclofen treatment in chronic schizophrenia: a clinical trial. Am J Psychiatry. 1977;134:318-320.
10. Soares KV, McGrath JJ. The treatment of tardive dyskinesia - a systematic review and meta-analysis. Schizophr Res. 1999;39:1-16.
11. Glazer WM, Moore DC, Bowers MB. The treatment of tardive dyskinesia with baclofen. Psychopharmacology (Berl). 1985;87:480-483.
12. Itil TM, Herkert E, Schneider SJ, et al. Baclofen in the treatment of tardive dyskinesia: open label study. Acta Ther. 1980;6:315-323.
13. Nair NP, Yassa R, Ruiz-Navarro J, et al. Baclofen in the treatment of tardive dyskinesia. Am J Psychiatry. 1978;135:1562-1563.
14. Kaplan GB, McRoberts RL 3rd, Smokler HJ. Baclofen as adjunctive treatment for a patient with cocaine dependence and schizoaffective disorder. J Clin Psychopharmacol. 2004;24:574-575.
15. Anton RF, Moak DH, Latham PK. The obsessive compulsive drinking scale: a new method of assessing outcome in alcoholism treatment studies. Arch Gen Psychiatry. 1996;53:225-231.
16. Janiri L, Calvosa F, Dario T, et al. The Italian version of the obsessive-compulsive drinking scale: validation, comparison with the other versions and difference between type 1- and type 2-like alcoholics. Drug Alcohol Depend. 2004;74:187-195.
17. Huguelet P, Morand-Collomb S. Effect of topiramate augmentation on two patients suffering from schizophrenia or bipolar disorder with comorbid alcohol abuse. Pharmacol Res. 2005;52:392-394.